Francesca Fumagalli

Lentiviral Hematopoietic Stem Cell Gene Therapy Benefits Metachromatic Leukodystrophy

Alessandra Biffi, Eugenio Montini, Laura Lorioli et al. · Science · 2013 · 1.2K citations · Full text

Cell Therapy, Immunology, Blood Cell +17

Lentiviral haemopoietic stem-cell gene therapy in early-onset metachromatic leukodystrophy: an ad-hoc analysis of a non-randomised, open-label, phase 1/2 trial

Maria Sessa, Laura Lorioli, Francesca Fumagalli et al. · The Lancet · 2016 · 496 citations

Ad-hoc Analysis, Cell Therapy, Bone Marrow Failure +8

Lentiviral haematopoietic stem-cell gene therapy for early-onset metachromatic leukodystrophy: long-term results from a non-randomised, open-label, phase 1/2 trial and expanded access

Francesca Fumagalli, Valeria Calbi, Maria Grazia Natali Sora et al. · The Lancet · 2022 · 266 citations · Full text

Metachromatic leukodystrophy – mutation analysis provides further evidence of genotype–phenotype correlation

Alessandra Biffi, Martina Cesani, Francesca Fumagalli et al. · Clinical Genetics · 2008 · 111 citations

Metachromatic leukodystrophy: A single‐center longitudinal study of 45 patients

Francesca Fumagalli, Alberto A. Zambon, Paola M. V. Rancoita et al. · Journal of Inherited Metabolic Disease · 2021 · 71 citations · Full text